This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe

€600 savings expire in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Peng Leong
CBO and Head of Brain Aging at BioAge
Speaker

Profile

Dr. Peng Leong leads efforts at BioAge to execute strategic transactions that convert prioritized drug targets into a portfolio of therapies for treating diseases of aging, and activities specific to brain aging. Peng has played a key role in building BioAge’s pipeline, including in-licensing Azelaprag that is being studied in an on-going Phase 2 trial for obesity, and establishing research collaborations with leading pharma companies. In prior roles at Merck KGaA, Chiron, Kazia Therapeutics, DRI Healthcare and investment banking, Peng acquired or sold billions of dollars in pharmaceutical product rights. Dr. Leong received his BSc and PhD in Biochemistry from the University of Toronto, Canada and an MBA from the University of California, Berkeley.

Agenda Sessions

  • “I’ve Been Waiting for You": Rise of novel cardiometabolic therapies

    17:00